Limitations of Fluorine 18 Fluoromisonidazole in Assessing Treatment-induced Tissue Hypoxia after Transcatheter Arterial Embolization of Hepatocellular Carcinoma: A Prospective Pilot Study-Reference-Cited by-同舟云学术

Limitations of Fluorine 18 Fluoromisonidazole in Assessing Treatment-induced Tissue Hypoxia after Transcatheter Arterial Embolization of Hepatocellular Carcinoma: A Prospective Pilot Study

Published:2022-05-01 Issue:3 Volume:4 Page:
ISSN:2638-616X
Container-title:Radiology: Imaging Cancer
language:en
Short-container-title:Radiology: Imaging Cancer

Author:

Shah Rajesh P.^ORCID,Laeseke Paul F.^ORCID,Shin Lewis K.,Chin Frederick T.,Kothary Nishita^ORCID,Segall George M.

Funder

Stanford University

National Institutes of Health Clinical and Translational Science Awards

Publisher

Radiological Society of North America (RSNA)

Subject

Religious studies,Cultural Studies

Link

http://pubs.rsna.org/doi/pdf/10.1148/rycan.210094

Reference29 articles.

1. American Cancer Society. Cancer Facts & Figures 2021. Atlanta, Ga:American Cancer Society,2021;72.

2. AASLD guidelines for the treatment of hepatocellular carcinoma

3. Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma

4. Hypoxia in cancer: significance and impact on clinical outcome

5. Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Hypoxia on Radiation-Based Therapies for Liver Cancer;Cancers;2024-02-22

2. Functional Imaging of Hypoxia: PET and MRI;Cancers;2023-06-25

3. Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma;Cancers;2023-03-25

4. PET Oncological Radiopharmaceuticals: Current Status and Perspectives;Molecules;2022-10-11